We inform you about the current business development of HAEMATO AG and about our investor relations activities.
In the first half of 2019, HAEMATO AG achieved EBITDA of EUR 1.69 million. Sales amounted to EUR 94.0 million. In the first six months of the financial year 2019, HAEMATO AG, Berlin (ISIN: DE0006190705), achieved an IFRS consolidated revenue of EUR 94.0 million...read more
HAEMATO AG published the Annual Report 2018 on 6 May 2019. In the first quarter of 2019, HAEMATO AG's sales amounted to EUR 48.4 million. HAEMATO AG, Berlin (ISIN: DE0006190705), published the Annual Report 2018 on 6 May 2019, as announced in advance in the financial...read more
In consideration of the IFRS 15 "Revenues", which is mandatory from the financial year 2018, HAEMATO AG generated IFRS Group sales of EUR 274.1 million, an operating result (EBIT) of EUR 8.5 million and a net income of EUR 6.3 million. In the second half of 2018, as a...read more
HAEMATO AG was able to achieve an EBITDA of EUR 10.0m for the fiscal year 2018 according to preliminary IFRS financial statements. HAEMATO AG, Berlin (ISIN: DE0006190705), achieved consolidated sales of EUR 274.1m (previous year: EUR 289.4m), an operating...read more
In the third quarter of 2018 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS consolidated sales of EUR 69.12 million (previous year: EUR 72.5 million). In the considered period of January till September 2018 the sales amounted to € 212.8 million...read more
In the first half of 2018, the HAEMATO Group increased sales by 3.6 % year-on-year to a total of EUR 143.7 million. EBIT amounted to kEUR 6,484.6 (prior year period: kEUR 3,182.8). The consolidated profit as of 30.06.2018 amounts to kEUR 5,044.5 and is therefore also...read more